Topic Listing for Orthovita

Accordance Sfas Accounting Research Development Costs Expense Expenses Accounting Consequences
Accounting Derivative Liability Associated Non-employee Stock Options Acknowledges Waived Right Trial Jury Action Proceeding
Acquire Technologies Businesses Companies Future Acquisitions Result Dilution Acquire Technologies Companies Future Acquisitions Result Dilution Shareholders
Acquire Technologies Products Businesses Future Acquisitions Result Disruption Adjustment Provision
Administration After Clearance Approval Products Subject Continuing Regulation Fda
Agreement Agreement Kensey Nash Corporation
Agreement Medafor Agreements Angiotech
Agreements Angiotech Pharmaceuticals Inc Agreements Messrs Smith Mcilhenny
Agreements Persenaire Agreements Relating Transaction Related Event Litigation Filed Written
Aliquot Delivery System Aliquot Micro Delivery System
Amended Restated License Agreement Amendment
Amendment Articles Incorporation Amendment Effective Date Closing
Amendment Termination Plan Amendments Bylaws
Amendments Waivers Angiotech Agreements
Angiotech-branded Costasis Products Annual Report Shareholders
Appendix Appraisal Rights
Arbitration Assignment
Assignment Agreement Audit Committee
Audit Committee Report Authorization
Authorized Shares Common Stock Balance Sheet Data
Base Salaries Basis Consolidation
Beneficial Ownership Reporting Compliance Bill Sale
Binding Effect Binding Effect Assignment Amendment Shall Inure Benefit Each
Binding Letter Intent Purchase Angiotech Royalty Rights Biomimetic Agreement
Board Directors Committees Board Independence
Bone Marrow Aspiration System Imbibe Needles Syringes Disposable Bone Marrow Aspiration System Imbibe Syringe Disposable Delivery
Brokers Fees Business Acquisition
Business Damaged Unable Protect Proprietary Rights Products Subject Business Suffer Cannot Attract Retain Services Key Employees
Cannot Keep Technological Changes Marketing Initiatives Competitors Sales Capitalization Subsidiaries
Cash Equivalents Investments Cash Flow Data
Cash Flows Provided Financing Activities Cash Flows Provided Investing Activities
Cash Flows Provided Used Investing Activities Cash Flows Used Operating Activities
Cautionary Regarding Forward-looking Statements Cellpaker Plasma Collection System
Certain Anti-takeover Provisions Certain Federal Income Tax Information
Certain Performance Requirements Certain Relationships Related Transactions
Certain Representations Warranties Certain Representations Warranties Covenants
Certain Risks Associated Potential Effects Proposed Reverse Stock Certain Risks Related Business
Certificates Opinions Certification
Certification Chief Executive Officer Certification Chief Financial Officer
Certifications Change Control Agreements Messrs Smith Low
Changes Annual Target Performance Bonus Program 2008 Changes Bonus Program Senior Vice President Sales Marketing
Changes Capitalization Changes Internal Control Over Financial Reporting
Closing Code Conduct
Collateral Documents Commitments Contingencies
Common Stock Common Stock Options
Common Stock Par Value Per Share Title Class Common Stock Purchase Warrants
Communicate Directors Communications Board
Comparative Stock Performance Graph Comparison 2003 2002
Comparison 2004 2003 Comparison 2005 2004
Comparison 2006 2005 Comparison 2007 2006
Comparison 2008 2007 Compensation Antony Koblish President Chief Executive Officer
Compensation Committee Compensation Committee Report
Compensation Discussion Analysis Competition
Compliance Erisa Compliance Laws
Comprehensive Loss Conditions Additional Advances
Conditions Applicable Orthovita Conditions Applicable Rst
Conference Call Confidential Information
Confidentiality Confidentiality Non-disclosure Agreement
Conflicts Consent Independent Registered Public Accounting Firm
Consent Release Consent Transfer
Consequences Change Control Consideration Director Candidates
Consolidated Statements Operations Contact
Contractual Obligation Commercial Commitments Contractual Obligations
Contractual Obligations Commercial Commitments Controls Procedures
Corporate Authorization Corporate Governance Guidelines Other Documents
Corporation Bureau Cortoss Bone Augmentation Material
Cortoss Pivotal Clinical Trial Status Cortoss Synthetic Cortical Bone
Costasis Surgical Hemostat Product Count Votes
Counterparts Effectiveness Counterparts Facsimile
Critical Accounting Policies Current Products Not Commercially Successful Increase Product Portfolio
Current Products Not Commercially Successful Operating Results Impaired D-1
D-2 Data Pivotal Cortoss Trial Not Sufficient Sufficiently Supportive
Date Deferrals
Definitions Departure Directors Certain Officers Election Appointment Compensatory
Departure Directors Principal Officers Election Appointment Dependent Kensey Other Third-party Manufacturers Supply Products Sell
Dependent Limited Number Specialized Manufacturing Suppliers Certain Products Dependent Limited Number Specialty Suppliers Certain Raw Materials
Description Employee Stock Purchase Plan Description Plan
Description Products Development Relationship
Did Committee Select Peer Group Compensation Survey Information Difficulties Operating International Markets Harm Sales Products
Directors Compensation Directors Executive Officers Registrant
Directors Independent Board Make Determination Disclosure Notice
Disposition Collateral Proceeds Documents Incorporated Reference
Effect Change Control Unvested Equity Awards Effect Options Warrants Other Securities
Effective 2003 Through 2004 Effective 2005
Effects Change Control Effects Ownership Individual Shareholders
Election Directors Eligibility
Eligibility Participation Employee Stock Purchase Plan
Employees Employment Agreement Low
Employment Agreements Messrs Koblish Pavucek Employment Arrangement Christopher Smith
Employment Arrangement Donald Scanlan Employment Change Control Agreements
Endoskeleton Devices Endoskeleton Structural Devices
Entire Agreement Entitled Vote
Entry Material Definitive Agreement Equipment
Equity Compensation Grants Equity Compensation Plan
Equity Compensation Plan Information 2007 Equity Compensation Plan Information 2008
Erbe Paiva European Union Other International Markets
Evaluation Disclosure Controls Procedures Event Default
Exact Name Registrant Specified Charter Exception
Exclusive Sales Distribution Agreement Executive Compensation Report Committee
Executive Officers Orthovita Executive Sessions Independent Directors
Exhibits Exhibits Reports Form 8-k
Expenses Explanatory
Fail Comply Fdas Quality System Regulation Manufacturing Operations Fail Meet Obligations Revenue Sharing Agreement Required Repurchase
Fail Obtain Maintain Necessary Fda Clearances Products Indications Fail Obtain Maintain Regulatory Approvals Clearances Necessary Make
Fail Obtain Maintain Regulatory Approvals Necessary Sell Products Federal Income Tax Consequences
Financial Results Financial Statements Exhibits
Financial Statements Supplementary Data Financials
Financing Cash Inflows Financing Cash Inflows-
Financing Cash Outflows Financing Cash Outflows-
Financing Requirements Outlook Financing Requirements Outlook-
Force Majeure Foreign Currency Risk
Form 10-k Form 10-q
Form Guaranty Supplement Form Incentive Stock Option Grant
Form Nonqualified Stock Option Grant Form Retention Plan Agreement Vice Presidents
Former Name Address Changed Since Last Report Former Revenue Interest Obligation
Forward Looking Information Forward-looking Statements
Fractional Shares Further Assurances
Future Sales Common Stock Public Market Adversely Affect Gain Sale Assets
General General Confirmations
General Development Business Governing Law
Governing Law Jurisdiction Government Regulation
Governmental Authorization Grants
Grants 2007 Plan Headings Captions
Health Care Fraud Abuse Laws Health Care Providers Cannot Obtain Third-party Reimbursement Procedures
Held 2005 Held 2006
Held 2007 Held 2008
Held 2009 Imbibe Bone Marrow Aspirate Delivery Devices Used Vitoss
Immediate Release Impairment Long-lived Assets
Important Notice Regarding Availability Proxy Materials Annual Meeting Incentive Stock Option Grant
Incentive Stock Options Incur Significant Liability Determined Promoting Off-label Medical Devices
Indemnification Non-exclusive Indemnification Officers Directors
Indemnification Procedure Independent Directors Meet Separately Regularly Scheduled Executive Sessions
Independent Nature Relationship Independent Registered Public Accountants
Index Information Furnished Prf
Intellectual Property Intellectual Property Security Agreement
Interpretation Inventories
Investing Cash Inflows Investing Cash Inflows-
Investing Cash Outflows Investing Cash Outflows-
Investing Cash Outlook Investing Cash Outlook-
Joint Committee Kensey Agreement
Know-how Kpmg Llp
Legal Proceedings Legend
License Agreement Liquidity Capital Resources
List Pledgors Litigation
Lock-up Agreement Lock-up Requirement
Losses Continue Long Term Limit Growth Orthopedic Industry Losses Continue Long Term They Limit Growth Orthopedic
Managements Annual Report Internal Control Over Financial Reporting Managements Report Internal Control Over Financial Reporting
Managements Responsibility Financial Reporting Managing Underwriters
Manufacture Products Orthovita Manufacturing Product Supply
Manufacturing Supply Agreement Market Acceptance Approved Products Below Expectations Inventory Valuation
Market Registrants Common Equity Related Stockholder Matters Market Risk
Material United States Federal Income Tax Consequences Messrs Smith Mcilhenny
Minimum Sales Miscellaneous
Modified Some Products Without Fda Clearance Retroactively Determine Monday 2008
Name Person Filing Proxy Statement Other Registrant Nasd Affiliations
Near-term Product Development Negative Changes Economic Conditions Adversely Affect Sales Business
Negatively Impacted Future Interpretation Implementation Federal State Fraud Net Cash Provided Financing Activities
Net Cash Provided Investing Activities Net Cash Provided Used Investing Activities
Net Cash Used Financing Activities Net Cash Used Investing Activities
Net Cash Used Operating Activities Net Cash Used Provided Financing Activities
Net Loss Per Common Share Nominating Corporate Governance Committee
Nominees Board Directors Nominees Board Selected
Non-gaap Disclosures Non-gaap Disclosures Reconciliation
Non-qualified Stock Options Nonqualified Stock Option Grant
Not Applicable Not Complete Pivotal Trial Cortoss Conducted Improperly Delay
Not Intend Pay Cash Dividends Common Shareholders Not Manage Commercial Scale Manufacturing Capability Capacity Products
Not Successfully Train Sufficient Number Surgeons Demand Products Not Successfully Train Sufficient Number Surgeons Products Demand
Notes Consolidated Financial Statements Notes Payable Capital Lease Obligations
Notice Notice Exercise Warrant
Notices Notices Demands Other Communications Given Delivered Reason Provisions
Number 0-24517 Number Shares Vesting
Numbers Products Still Subject Royalty Offering Period
Often Did Board Meet 2006 Often Did Board Meet 2007
Often Did Board Meet 2008 Operating Cash Flow Requirements Outlook
Operating Cash Flow Requirements Outlook- Operating Cash Inflows
Operating Cash Inflows- Operating Cash Outflows
Operating Cash Outflows- Opinion Orthovita Inc Subsidiaries Maintained Material Respects Effective
Option Exercises Stock Vested 2006 Option Exercises Stock Vested 2007
Option Exercises Stock Vested 2008 Options
Organization Orm Ote
Orm Otice Dditional Dvances Orm Ssignment Ssumption
Orthovita Announces 2009 Sales Orthovita Inc
Orthovita Inc Subsidiaries Orthovita Indemnification
Orthovita Reports 2007 Financial Results Orthovita Reports 2007 Year-end Financial Results
Orthovita Reports 2008 Financial Results Orthovita Reports 2009 Financial Results
Other Accrued Expenses Other Documents Deliveries
Other Effects Shares Common Stock Other Events
Other Information Other Sales Corporate Information
Other Stock-based Awards Outstanding 2009
Overview Overview General Development Business
Ownership Part
Part Other Information Participation
Participation Plan Benefits Patents Proprietary Intellectual Property
Payments Reports Orthovita Payments Respect Assigned Interests
Payroll Deductions Performance Bonus Objectives
Performance Bonus Objectives Target Amounts Performance Bonuses
Performance-based Equity Awards Pivotal Cortoss Trial Not Yield Supportive Sufficient Data
Plan Assume Manufacturing Products Licensed Angiotech Not Successful Plan Assume Manufacturing Vitagel Not Successful
Plan Assume Manufacturing Vitagel Related Products Not Successful Please Sign Date Promptly Return Proxy Card Enclosed
Potential Anti-takeover Effect Potential Payments Termination Change Control
Pre-approval Policies Procedures Preferred Stock
Preparation Financial Statements Estimates Prf Indemnification
Price Numbers Products Supplied Cohesion Between Effective Date Pricing-related Information
Principal Accounting Fees Services Principal Warrant Documents
Procedure Effecting Proposed Reverse Stock Split Exchange Certificates Product Development Milestones
Product Liability Insurance Product Sales
Products Product Candidates Profit Sharing Plan
Properties Property Equipment
Proposal 1-election Directors Proposal 2-to Approve Increase Number Shares Common Stock
Proposal 3-approval 2007 Omnibus Equity Compensation Plan Proposal 4-ratification Appointment Independent Registered Public Accounting Firm
Proposal Amend Restate 1997 Equity Compensation Plan Proposal Approve Amended Restated Employee Stock Purchase Plan
Proposal Ratification Appointment Independent Registered Public Accounting Firm Prospectus Delivery
Provisions Pennsylvania Law Articles Incorporation Deter Party Seeking Provisions Pennsylvania Law Articles Incorporation Deter Third-party Seeking
Proxies Solicited Proxy Solicited Behalf Board Directors Orthovita Inc
Proxy Statement Purchase Price
Purchase Sale Purchase Sale Agreement
Purchase Shares Issuance Certificates Purpose
Purpose Effect Proposed Amendment Restatement Purpose Proposed Reverse Stock Split
Pursuant 302 Qualified Performance-based Compensation
Quantitative Qualitative Disclosures Market Risk Quarterly Period 2005
Quarterly Period 2006 Quarterly Period 2007
Quarterly Period 2008 Quarterly Period 2009
Receipt Agreements Recent Developments
Recently Issued Accounting Pronouncements Recitals
Registrants Telephone Including Area Code 610 640-1775 Registrants Telephone Number Including Area Code 610 640-1775
Registration Listing Common Stock Registration Rights Agreement
Registration Shares Registration Statement Purchase Price Shares
Regulatory Matters Reliance Certain Representations Warranties
Removal Legend Report Audit Committee
Report Compensation Committee Report Independent Registered Public Accounting Firm
Representations Warranties Orthovita Representations Warranties Rst
Requirements Issuance Shares Research Development
Respectfully Submitted 2007 Members Audit Committee Board Directors Respectfully Submitted 2007 Members Compensation Committee Board Directors
Respectfully Submitted 2008 Members Audit Committee Board Directors Respectfully Submitted 2009 Members Audit Committee Board Directors
Responsible Determining Compensation Philosophy Restricted Securities
Restricted Stock Awards Restricted Stock Unit Agreement
Restricted Stock Units Restrictions Transfer
Restrictive Covenants Smith Results Operation
Results Operations Results Operations Financial Condition
Results Operations Fluctuate Due Factors Out Control Cause Retention Plan Agreement Vice Presidents
Revenue Interest Obligation Revenue Interests Assignment Agreement
Review Approval Ratification Transactions Related Persons Revoke Proxy
Risk Factors Risks Uncertainties Found Orthovitas Filings Sec Available Well
Royalty Sale Agreement Sales Marketing
San Francisco Sarbanes-oxley Act 2002
Sars Schedule
Schedule Buyers Schedules
Scott Barry Paul Thomas William Tidmore Join Orthovita Securities Disposition Agreement
Securities Purchase Agreement Securities Registered Pursuant Act
Security Agreement Joinder Security Interest
Security Ownership Certain Beneficial Owners Management Seek Obtain Additional Funds Through Borrowings Other Debt
Senior Secured Purchase Facility Severability
Shareholder Proposals Shareholder Proposals 2008 Annual Meeting
Shareholder Proposals 2009 Annual Meeting Shareholder Proposals 2010 Annual Meeting
Shareholder Recommend Candidate Nomination Director Orthovita Shareholders Equity
Shares Authorized Issuance 2007 Plan Shares Represented Proxy Voted Directed Undersigned Direction Given
Shares Subject Plan Shares Vote
Short Position Signature
Signature Page Assignment Agreement Signature Page Consent Release
Signature Page Follows Signature Page Purchase Sale Agreement
Signature Page Securities Disposition Agreement Signature Pages Follow
Signatures Signatures Following Page
Significant Contractual Obligations Solvency
Special Meetings Specific Performance
Stock Appreciation Rights Stock Awards
Stock Options Stock Performance Graph
Stock Price Volatile Stock Units
Stockholder Proposals Submission Matters Vote Security Holders
Subsequent Event Subsidiaries
Subsidiaries Acquisitions Investments Subsidiary Intellectual Property Security Agreement
Successors Assigns Sued Product Liability Action Forced Incur Substantial Defense
Sued Product Liability Action Forced Pay Substantial Damages Suitability Investment
Summary Financial Information Supply License Agreement
Survival Suspension Sales
Table Contents Tax Withholding
Term Termination Termination Employment
Termination Events Termination Security Interests
Third-party Reimbursement Title Class
Touch-tone Telephone Trademarks
Transactions Related Persons Transfer Restrictions
Transfer Stock Options Transferability Awards
Transferability Grants Trustee Capacity
Tuesday 2008 Unable Increase Sales Approved Products Operating Results Affected
Unable Operate Effective Sales Distribution Network Ability Generate Unapproved Off-label Products Adversely Affect Reputation
Undesignation Series Preferred Stock United States
Unregistered Sales Equity Securities Proceeds Updated 2009 Financial Guidance
Usc 1350 Valuation Qualifying Accounts
Vitagel Surgical Hemostat Vitagel Surgical Hemostat Accessories
Vitasure Absorbable Hemostat Vitasure Distribution Agreement
Vitomatrix Supply Agreement Vitoss Bone Graft Substitute
Vitoss Not Commercially Successful United States Cortoss European Vote
Vote Confidential Vote Internet
Vote Today Ways Voting Other Business Conducted
Waiver Waiver Amendment Limited Specified Execution Delivery Effectiveness Shall
Waiver Jury Trial Warrant Been Issued Connection Execution Clinical Assessment Agreement
What Broker Non-votes What Committees Board Functions
What Composition Board Often Members Elected What Individual Components Executive Compensation Program Choose Pay
What Objectives Executive Compensation Program What Policy Regarding Board Members Attendance Annual Meeting
What Principles Board Established Respect Corporate Governance What Process Committee Follow Implement Executive Compensation Program
What Proposals Vote Annual Meeting Board Recommend What Quorum
What Significant Tax Accounting Considerations Executive Compensation What Vote Required Approve Each Proposal
Withdrawal Withholding Taxes
Xhibit Icense Greement 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki